Macquarie Group’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-41,538
Closed -$13.5M 2197
2024
Q1
$13.5M Sell
41,538
-96,899
-70% -$23.8M 0.02% 758
2023
Q4
$26.4M Sell
138,437
-81,416
-37% -$15.4M 0.03% 608
2023
Q3
$43.8M Sell
219,853
-43,239
-16% -$10.2M 0.06% 438
2023
Q2
$75.1M Sell
263,092
-208,291
-44% -$57.8M 0.09% 309
2023
Q1
$102M Sell
471,383
-284,625
-38% -$55.5M 0.12% 229
2022
Q4
$155M Sell
756,008
-208,801
-22% -$52.8M 0.18% 130
2022
Q3
$268M Sell
964,809
-152,328
-14% -$38.7M 0.33% 57
2022
Q2
$214M Buy
1,117,137
+232,570
+26% +$41.1M 0.24% 83
2022
Q1
$183K Buy
884,567
+343,144
+63% +$56.6M 0.14% 151
2021
Q4
$96.6M Buy
541,423
+45,553
+9% +$8.98M 0.08% 313
2021
Q3
$102M Sell
495,870
-130,152
-21% -$25.6M 0.09% 294
2021
Q2
$119M Sell
626,022
-18,476
-3% -$3.02M 0.1% 259
2021
Q1
$84M Sell
644,498
-39,760
-6% -$4.77M 0.12% 202
2020
Q4
$71M Buy
684,258
+116,410
+21% +$10.1M 0.1% 222
2020
Q3
$43M Buy
567,848
+10,447
+2% +$592K 0.07% 301
2020
Q2
$26.4M Buy
+557,401
New +$23M 0.05% 407

Other funds holding SWAV

Macquarie Group's SWAV Position: Q2 2024 in Review

Macquarie Group sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 41,538 shares — an estimated $13.5M sold.

Macquarie Group first reported a position in SWAV in Q2 2020 and held it in 16 quarters. The position peaked at $268M in Q3 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Macquarie Group reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Macquarie Group sold 41,538 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $13.5M.
  • Macquarie Group first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2020 and held it in 16 quarters.
  • Macquarie Group's Shockwave Medical, Inc. Common Stock position peaked at $268M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Macquarie Group's 13F filing for Q2 2024, filed 9 Aug 2024.